| Name | Title | Contact Details |
|---|
Phunware is the pioneer of Multiscreen as a Service (MaaS) – the only fully integrated services platform that enables brands to engage, manage and monetize their anytime, anywhere users. Phunware has introduced category defining experiences that challenge the outer limits of the most advanced multiscreen devices for the world`s most respected brands.
Inovalon is a leading technology company providing cloud-based platforms empowering a data-driven transformation from volume-based to value-based models throughout the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and industry-leading subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon`s unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Providing technology that supports nearly 500 healthcare organizations, Inovalon`s platforms are informed by data pertaining to more than 903,000 physicians, 385,000 clinical facilities, and more than 231 million unique patients.
Video Communications Incorporated is a Springfield, MA-based company in the Software & Internet sector.
Forcepoint is the human-centric cybersecurity company that understands behavior and adapts security response and enforcement to risk. The Forcepoint Human Point platform delivers Risk-Adaptive Protection to continuously ensure trusted use of critical data and systems. Based in Austin, Texas, Forcepoint protects data and identities for thousands of enterprise and government customers in more than 150 countries.
Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.